These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 401003)

  • 41. Psychotropic effects of antiepileptic drugs.
    Ettinger AB
    Neurology; 2006 Dec; 67(11):1916-25. PubMed ID: 17159095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance and mutations of non-specificity in the field of anxiety-depressive disorders in Canadian medical journals, 1950-1990.
    Collin J; Otero M
    Soc Sci Med; 2015 Apr; 131():228-38. PubMed ID: 25533142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of non-steroidal anti-inflammatory and psychotropic drugs in patients with rheumatoid arthritis].
    Korshunov NI; Baranova EIa
    Ter Arkh; 1984; 56(11):77-81. PubMed ID: 6395430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basic mechanisms of psychotropic drugs.
    Ebert U
    Epilepsia; 2002; 43 Suppl 2():2-7. PubMed ID: 11903475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.
    Ohayon MM; Lader MH
    J Clin Psychiatry; 2002 Sep; 63(9):817-25. PubMed ID: 12363124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The elderly, sleep habits and use of psychotropic drugs by the French population].
    Ohayon M; Caulet M; Lemoine P
    Encephale; 1996; 22(5):337-50. PubMed ID: 9035990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methodological and theoretical aspects of the evaluation of psychotropic drugs in normal healthy volunteers (author's transl)].
    Debus G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):109-18. PubMed ID: 360235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anxiety, depression, psychotropic drug use and cognitive impairment.
    Paterniti S; Dufouil C; Bisserbe JC; Alpérovitch A
    Psychol Med; 1999 Mar; 29(2):421-8. PubMed ID: 10218933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-injury depression and anxiety in patients with orthopedic trauma and their treatment.
    Haupt E; Vincent HK; Harris A; Vasilopoulos T; Guenther R; Sharififar S; Hagen JE
    Injury; 2018 Jun; 49(6):1079-1084. PubMed ID: 29636184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychotropic drugs in dermatology. A review and guidelines for use.
    Gupta MA; Gupta AK; Haberman HF
    J Am Acad Dermatol; 1986 Apr; 14(4):633-45. PubMed ID: 2870093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Change in psychotropic drug use among community-dwelling people aged 75 years and older in Finland: repeated cross-sectional population studies.
    Desplenter F; Caenen C; Meelberghs J; Hartikainen S; Sulkava R; Bell JS
    Int Psychogeriatr; 2011 Oct; 23(8):1278-84. PubMed ID: 21554797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Planning of psychotropic drug trials. Seminar at Jongny, Switzerland, 16-18 March 1977].
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):105-204. PubMed ID: 30097
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychotropic treatment during pregnancy.
    Pinkofsky HB; Fitz-Gerald MJ; Reeves RR
    Am J Psychiatry; 1997 May; 154(5):718-9. PubMed ID: 9137147
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning.
    Gainotti G; Benedetti N; Caltagirone C; Nocentini U
    Clin Neuropharmacol; 1986; 9 Suppl 3():S65-9. PubMed ID: 3297320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nosospecific anxiety and a spectrum of anxiolytic activity of psychotropic drugs].
    Kozlovskii VL; Ronzhina OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(4):96-101. PubMed ID: 28617389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of long term use of psychotropic drugs by general practice patients.
    Mant A; Duncan-Jones P; Saltman D; Bridges-Webb C; Kehoe L; Lansbury G; Chancellor AH
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):251-4. PubMed ID: 2893650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do volunteer subjects bias clinical trials?
    Amori G; Lenox RH
    J Clin Psychopharmacol; 1989 Oct; 9(5):321-7. PubMed ID: 2794097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescribing rates for psychotropic medication amongst east London general practices: low rates where Asian populations are greatest.
    Hull SA; Cornwell J; Harvey C; Eldridge S; Bare PO
    Fam Pract; 2001 Apr; 18(2):167-73. PubMed ID: 11264267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.